Which version of the Instructions for Use did your doctors's office give you?
If you don’t recognize the images above or if you prefer a physical copy, contact your doctor.
Which version of the Instructions for Use came with your patient's on-body injector?
Neulasta® (pegfilgrastim) is a prescription medicine used to help reduce the... Read More
Neulasta® (pegfilgrastim) is a prescription medicine used to help reduce the chance of infection due to a low white blood cell count, in people with certain types of cancer (non‑myeloid), who receive anti-cancer medicines (chemotherapy) that can cause fever and low white blood cell count.
Learn more about strong chemo, white blood cells, and protecting yourself from infection and hospitalization.
Today, the risk of contracting viral infections makes it important to avoid return visits to the hospital or clinic when possible. Avoid exposure to viral infections by receiving Neulasta® at home.
†For eligible commercially insured patients, up to annual limit.
Click below for resources‡ that include product downloads, community organizations, and FAQs. You can also sign up for updates on Neulasta® Onpro®.See Patient Resources
* If, for any reason, you believe you did not receive your full dose of Neulasta® or that your on-body injector is not working correctly, immediately contact your healthcare provider, as an incomplete dose could increase infection risk.
‡Resources include referrals to independent nonprofit patient assistance programs. Eligibility for resources provided by independent nonprofit patient assistance programs is based on the nonprofits' criteria. Amgen has no control over these programs and provides referrals as a courtesy only.
Do not take Neulasta® if you have had a serious allergic reaction to pegfilgrastim or filgrastim.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
The most common side effect of Neulasta® is pain in your bones and in your arms and legs.
These are not all the possible side effects of Neulasta®. Call your healthcare provider for medical advice about side effects. You may report negative side effects to the FDA at 1-800-FDA-1088.
Please see Neulasta® Patient Information.
Neulasta® Injection: 6 mg/0.6 mL in a single-dose prefilled syringe for manual use only.
Neulasta® Injection: 6 mg/0.6 mL in a single-dose prefilled syringe co-packaged with the on-body injector (OBI) for Neulasta® (Neulasta® Onpro® kit).
Important Safety Information
Do not take take Neulasta® if you have had a serious allergic reaction to pegfilgrastim or filgrastim.
Before you receive Neulasta®, tell your healthcare provider about all of your healthcare conditions, including if you:
• Have a sickle cell disorder